Skip to content

Reduction of Recurrence of Stroke by Nurse-led Education in Bangladesh

Effectiveness of Health Education Program Among Patients & Family Caregivers on Modifiable Risk Factors mRS 0 to 4 to Reduce Recurrence of Stroke After Discharge From a Tertiary Hospital in Bangladesh

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05520034
Enrollment
432
Registered
2022-08-29
Start date
2022-10-02
Completion date
2026-03-30
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Stroke, Caregiver, Recurrence of stroke, Health education, Bangladesh

Brief summary

Stroke is a major public issue that can be occurred a patient with severe and unbearable disability for a long time. Recurrence of stroke is increasing due to a lack of knowledge and compliance with treatment regarding the modifiable risk factors of stroke and behavioral and lifestyle changes. Nurse-led health education with (self) monitoring of modifiable risk factors and behaviors can be an effective way to create knowledge about the behavioral changes in stroke patients. The investigators hypothesized that health education among first stroke patients and their family caregivers could reduce the stroke recurrence rate by controlling modifiable risk factors compared to the first stroke patients without health education.

Detailed description

In Bangladesh, the top cause of death per 100,000 population for both sexes aged all ages in 2019 is stroke. About 79.9 percent of the total patients were suffering from ischemic stroke, and 15.7 percent and 4.6 percent were diagnosed with hemorrhagic and subarachnoid hemorrhage respectively. One study found the cumulative recurrence rate was 14.7% at three months, 15.3% at six months, 17.3% at the ninth month, and 20% at one year (n=150). This study aims to evaluate the effect of health education among first-stroke patients and their family caregivers for reducing the recurrence of stroke. The investigators also assess the number and rate of all adverse events, changes in values of modifiable risk factors, and change scores in knowledge, lifestyle behavior, medication adherence, and QoL. In this study, participants were the first stroke patients who were discharged from the National Institute of Neurosciences & Hospital (NINSH) and the family caregivers of the patients. Written informed consent is received from the patient when the patient is the main person of self-management of recurrence prevention, if the patient cannot give consent by disability, his/her family caregiver provided consent. At baseline, blood specimens such as blood total cholesterol, HDL-cholesterol, HbA1c, and diagnosis including adverse events and blood pressure measurement data were obtained from the hospital records/patient's chart. At first, the research assistant (RA) nurse should confirm the written consent form for the participants. Then, the RA nurse took the baseline data through the interview. The raw data is stored and locked in secured places in NINSH. Confidentiality of data is of utmost importance; therefore, every effort is made to safeguard the identity of participants and protect subject privacy. All hard copies of data are stored under lock and kept in the NINSH. The sample size was based on the calculation of a 10% reduction in recurrence rate compared with the control group with a statistical power of 80% at α= 0.05 (2-tailed). Considering the dropout rate of 10%, the final sample size is 432 (2 arms). To compare the outcomes of the Intervention Group and Control Group, an intention-to-treat (ITT) analysis and a full analysis set (FAN) were conducted. Descriptive analysis was done to assess the baseline data. For categorical data, the chi-square (X2) test, and for continuous variables, the t-test, or Mann-Whitney U test was employed to compare the two groups where appropriate. For secondary endpoints, after adjusting for confounding variables such as age, an analysis of covariance (ANCOVA) was used to assess the effect of the intervention on the outcomes. To compensate for missing data, the last observation carried forward was measured. The significance level will be set at P=0.05. Data will be analyzed using SPSS (version 26.0; IBM Corp). In 5% of the study participants, the quality control team independently checked the collected data on the same day using a field-tested methodology. Detected errors were corrected immediately at the field site. The findings of the quality control team are considered for necessary corrections if any major discrepancies are found.

Interventions

BEHAVIORALHealth Education

The participants received a 45mins, face-to-face group health education after enrollment and during the 6th month by a RA nurse. Participants received the same health education over the phone call if the patient and family caregiver could not come for any reason. They also received a digital BP machine, a salt-measurement spoon, a medication box, and a recording notebook for monitoring. The intervention group receives health education above and reminder telephone calls provided by research assistant nurses every month (1st month to 3rd month: twice a month, and 4th month to 12th month: once a month)

Sponsors

National Institute of Neuro Sciences & Hospital, Bangladesh
CollaboratorOTHER_GOV
Hiroshima University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Masking description

Two-arm open-label study

Intervention model description

Randomized control trial (RCT) study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

For patient 1. Who was discharged from NINSH to home or who visited NINSH right after getting a stroke 2. First-time stroke 3. All types of strokes, except subarachnoid haemorrhage 4. modified Rankin Scale (0 - 4) 5. Stroke patient who is 18 years old and above 6. Both males & females 7. Who provided written consent & willing to participate in the study For family caregivers 1. Primary caregivers irrespective of sex and aged 18 years old and above, living with the patient who take care of an above patient and who meets all of the inclusion criteria (will be decided by one person) 2. Who will provide written consent & willing to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Change of the recurrence rate of stroke.12 monthsCompare the recurrence rate of stroke between the intervention group and the control group

Secondary

MeasureTime frameDescription
Change of the number of adverse events12 monthsCompare the number of all causes of death, and cardiovascular events between the intervention group and the control group. The adverse event refers that all cases that need to be diagnosed: for example, new onset of acute myocardial infarction (AMI) and unstable angina, heart failure (with hospitalization), PAD (peripheral arterial disease: hospitalization)
Change in values of blood pressure level12 monthsCompare value of blood pressure (mmHg) between the intervention group and the control group.
Change in value of HbA1c12 monthsCompare value of HbA1c (%) between the intervention group and the control group.
Changes in scores in medication adherence12 monthsCompare scores of behavior changes in medication adherence measured by a Medication adherence related questionnaire between the intervention group and the control group. The questionnaire consists of 4 items with Yes=0 and No=1 answers. The score ranges from 0-4, and a higher score indicates better compliance.
Changes in scores in knowledge related to stroke12 monthsCompare scores in knowledge related to stroke (the researcher-developed Knowledge questionnaire of stroke) between the intervention group and the control group. The questionnaire consists of 10 items with No/Wrong answer, Yes/Correct answer, and Don't know answers. The score ranges from 0-20, and a higher score indicates having better knowledge.
Changes in scores in lifestyle behavior related to stroke12 monthsCompare scores in lifestyle behavior related to stroke (the researcher-developed Lifestyle behavior questionnaire related to stroke) between the intervention group and the control group. The questionnaire consists of 14 items (6 items will not be counted) with a Likert scale with the frequency of behaviors. The score ranges from 0-37, and a higher score indicates having better lifestyle behavior.
Changes in scores in QoL12 monthsCompare behavior changes in QoL measured by a WHOQOL- BREF Bangla Version-2 items) between the intervention group and the control group. Each item scores from 1 (very poor/very dissatisfied) to 5 (very good/very satisfied), and ranges (mean of 2 items) from 1 to 5, a higher mean indicates a better QoL.
Change in non-HDL cholesterol12 monthsCompare value of non-HDL cholesterol (mg/dl) (total cholesterol minus HDL cholesterol) between the intervention group and the control group.

Countries

Bangladesh

Contacts

Primary ContactMahabuba Afrin, PhD
mahabuba.a32@gmail.com+8108057903018
Backup ContactDr.Subir Chandra Das, MBBS
drsubir12@gmail.com+8801716450560

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026